Skip to main
ADUS

Addus HomeCare (ADUS) Stock Forecast & Price Target

Addus HomeCare (ADUS) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 13%
Sell 13%
Strong Sell 0%

Bulls say

Addus HomeCare Corp has demonstrated strong organic revenue growth, specifically a remarkable increase of 12.3% year-over-year in 2023, which is expected to moderate to 7.7% in 2024 and 7.4% in 2025 YTD, indicating a resilient demand for its personal care services. The recent announcement of a 2.6% Medicare Hospice rate increase, effective October 2025, provides a favorable regulatory environment that is poised to enhance the profitability of its Hospice segment. Additionally, as this segment stabilizes, potential mergers and acquisitions, alongside operational improvements, are identified as key contributors to sustained revenue growth in the coming years.

Bears say

Addus HomeCare has experienced same-store declines in 2025 year-to-date due to ongoing Medicaid redeterminations, which have caused administrative bottlenecks in onboarding new patients and resulted in higher discharge rates compared to admissions. Approximately 97% of the company's segment revenues are affected by the uncertain Medicaid funding environment, especially in light of the One Big Beautiful Bill Act (OBBBA), which raises concerns about future revenue stability. Despite maintaining a favorable long-term demand backdrop and steady execution, the disconnect between Addus's equity valuation and its fundamental earnings trajectory indicates potential vulnerabilities in its financial outlook.

Addus HomeCare (ADUS) has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 13% suggest Holding, 13% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Addus HomeCare (ADUS) Forecast

Analysts have given Addus HomeCare (ADUS) a Buy based on their latest research and market trends.

According to 8 analysts, Addus HomeCare (ADUS) has a Buy consensus rating as of Feb 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $135.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $135.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Addus HomeCare (ADUS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.